Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1996 Jan;22(1):39-43.
doi: 10.1111/j.1524-4725.1996.tb00569.x.

Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study

Clinical Trial

Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study

A Garcia et al. Dermatol Surg. 1996 Jan.

Abstract

Background: Botulinum toxin has been used for facial hemispasm, strabismus, and blepharospasm. Recently it has been advocated to treat the frown lines. We have extended this program to treatment of other muscles of facial expression.

Methods: Botulinum toxin is injected into the muscles of facial expression in two or three sessions to produce a temporary loss of muscle tone. A standard method of cooling, injection, and compression was developed to minimize pain and bruising.

Objective: To complete a dose-response study to document the optimum timing and amount of toxin needed for each muscle group.

Results: Two to five Botulinum toxin units per muscle was as adequate as higher doses. Toxin that was reconstituted 30 days earlier produced the same loss of muscle tone as freshly mixed toxin. With two or three injection sessions loss of muscle tone lasted for up to 1 year.

Conclusion: Botulinum toxin is highly effective as an adjuvant therapy for facial rejuvenation. This minor surgical procedure can temporarily reduce the lines on the upper face and produce a pleasing effect. With proper dosing and dilution this rejuvenation program becomes cost effective.

PubMed Disclaimer

Comment in

  • Botox concerns.
    Carruthers A, Carruthers J. Carruthers A, et al. Dermatol Surg. 1997 Apr;23(4):308-9. doi: 10.1111/j.1524-4725.1997.tb00053.x. Dermatol Surg. 1997. PMID: 9149801 No abstract available.

Publication types

Substances